Cargando…
Staphylococcus aureus : molecular and clinical aspects /
Staphylococcus aureus is resident in skin and nasal membranes with a formidable pathogenic potential to cause a variety of community and hospital acquired infections. This authoritative survey covers the impact of genome sequences into our understanding of MRSA and MSSA pathogenesis. World specialis...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Chichester, U.K. :
Horwood Pub.,
2004.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn869282358 | ||
| 003 | OCoLC | ||
| 005 | 20231120111517.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140128s2004 enka ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OPELS |d YDXCP |d EBLCP |d MHW |d DEBSZ |d OCLCQ |d CNCGM |d OCLCF |d OCLCO |d D6H |d OCLCO |d CHVBK |d OCLCQ |d S2H |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d COM |d OCL |d OCLCQ |d OCLCO | ||
| 019 | |a 871225300 |a 1054889677 | ||
| 020 | |a 9780857099907 |q (electronic bk.) | ||
| 020 | |a 0857099906 |q (electronic bk.) | ||
| 020 | |z 1898563969 | ||
| 020 | |z 9781898563969 | ||
| 035 | |a (OCoLC)869282358 |z (OCoLC)871225300 |z (OCoLC)1054889677 | ||
| 050 | 4 | |a QR201.S68 |b S855 2004eb | |
| 060 | 4 | |a 2004 H-643 | |
| 060 | 4 | |a QW 142.5.C6 |b S7939 2004 | |
| 072 | 7 | |a SCI |x 008000 |2 bisacsh | |
| 072 | 7 | |a SCI |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 579.3/53 |2 22 |
| 245 | 0 | 0 | |a Staphylococcus aureus : |b molecular and clinical aspects / |c editors, Dlawer A.A. Ala'Aldeen, Keiichi Hiramatsu. |
| 264 | 1 | |a Chichester, U.K. : |b Horwood Pub., |c 2004. | |
| 300 | |a 1 online resource (xiv, 267 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a Staphylococcus aureus is resident in skin and nasal membranes with a formidable pathogenic potential to cause a variety of community and hospital acquired infections. This authoritative survey covers the impact of genome sequences into our understanding of MRSA and MSSA pathogenesis. World specialists from America, Germany, Japan, Sweden and the UK contribute knowledge and experience which will be welcome to researchers, practitioners and postgraduate students of immunology, microbiology, bacteriology and pharmacology worldwide. An authoritative survey that covers the impact of genome sequences into the understanding of MRSA and MSSA pathogenesisWorld specialists from America, Germany, Japan, Sweden and the UK contribute knowledge and experience. | ||
| 505 | 0 | |a Front Cover; Staphylococcus Aureus: Molecular and Clinical Aspects; Copyright Page; Table of contents; Chapter contributors; Preface; Chapter 1. Staphylococcal Infection: Emerging Clinical Syndromes; 1.1 INTRODUCTION; 1.2 BACTERAEMIA; 1.3 ENDOVASCULAR INFECTION; 1.4 BREAST INFECTIONS; 1.5 CELLULITIS; 1.6 DENTAL; 1.7 DIALYSIS-RELATED INFECTIONS; 1.8 EYE INFECTIONS; 1.9 ENTEROCOLITIS; 1.10 INTRA-ABDOMINAL; 1.11 CENTRAL NERVIOUS SYSTEM; 1.12 MYOCARDITIS/ PERICARDITIS; 1.13 NASAL COLONIZATION; 1.14 OSTEOMYELITIS/DISCITIS/ DIABETIC FOOT; 1.15 PAROTITIS; 1.16 RESPIRATORY INFECTIONS. | |
| 505 | 8 | |a 1.17 SURGICAL SITE INFECTIONS1.18 SMALL COLONY VARIANTS OF SA; 1.19 TOXIC SHOCK SYNDROME; 1.20 URINARY TRACT INFECTION; 1.21 VASCULAR INFECTIONS; 1.22 CONCLUSION; ACKNOWLEDGMENT; REFERENCES; Chapter 2. Epidemiology of MRSA and MSSA; 2.1 RESERVOIRS; 2.2 THE POPULATION STRUCTURE OF S. AUREUS; 2.3 ROUTES OF TRANSMISSION; 2.4 THE HOST POPULATION; 2.5 CONCLUSIONS; REFERENCES; Chapter 3. The Staphylococcus aureus Genome; 3.1 INTRODUCTION; 3.2 PHYSICAL PROPERTIES OF S. AUREUS GENOME; 3.3 FUNCTIONAL ORGANIZATION OF S. aureus GENOME; 3.4 POLYMORPHISM OF S. AUREUS GENOME AND GENOME ALLOTYPING. | |
| 505 | 8 | |a 3.5 CONCLUSIONACKNOWLEDGEMENT; REFERENCES; Chapter 4. Virulence Gene Regulation and their role in pathogenesis of disease; 4.1 INTRODUCTION; 4.2 THE ACCESSORY GENE REGULATOR, agr.; 4.3 THE SarA FAMILY OF TRANSCRIPTION FACTORS; 4.4 SIGMA FACTOR B; 4.5 TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEMS; 4.6 ROLE OF VIRULENCE REGULATORS IN INFECTION; REFERENCES; Chapter 5. Pathogenesis of disease; 5.1 INTRODUCTION; 5.2 S. AUREUS ENCAPSULATION; 5.3 BIOFILM FORMATION; 5.4 ADHERENCE; 5.5 COLONIZATION; 5.6 IRON ACQUISITION; 5.7 INTERNALIZATION OF S. AUREUS BY NON-PROFESSIONAL PHAGOCYTES. | |
| 505 | 8 | |a 5.8 STAPHYLOCOCCAL EXOTOXINSACKNOWLEDGEMENTS; REFERENCES; Chapter 6. Antimicrobial Resistance and Therapy of Staphylococcus aureus Infections; 6.1 BASIC MECHANISMS OF RESISTANCE; 6.2 BETA-LACTAM ANTIBIOTICS; 6.3 GLYCOPEPTIDES; 6.4 MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS; 6.5 LINEZOLID; 6.6 FLUOROQUINOLONES; 6.7 RIFAMPIN; 6.8 MISCELLANEOUS AGENTS; 6.9 THERAPEUTIC CONSIDERATIONS; REFERENCES. | |
| 650 | 0 | |a Staphylococcus aureus. | |
| 650 | 0 | |a Staphylococcus aureus infections. | |
| 650 | 0 | |a Staphylococcus aureus infections |x Epidemiology. | |
| 650 | 0 | |a Staphylococcus aureus infections |x Pathogenesis. | |
| 650 | 0 | |a Staphylococcus aureus |x Genetics. | |
| 650 | 0 | |a Drug resistance in microorganisms. | |
| 650 | 2 | |a Staphylococcal Infections |x epidemiology |0 (DNLM)D013203Q000453 | |
| 650 | 2 | |a Staphylococcus aureus |x genetics |0 (DNLM)D013211Q000235 | |
| 650 | 2 | |a Drug Resistance, Bacterial |0 (DNLM)D024881 | |
| 650 | 2 | |a Staphylococcus aureus |x pathogenicity |0 (DNLM)D013211Q000472 | |
| 650 | 2 | |a Staphylococcus aureus |0 (DNLM)D013211 | |
| 650 | 6 | |a Staphylococcus aureus. |0 (CaQQLa)201-0092165 | |
| 650 | 6 | |a Infections �a Staphylococcus aureus. |0 (CaQQLa)201-0368280 | |
| 650 | 6 | |a Infections �a Staphylococcus aureus |0 (CaQQLa)201-0368280 |x �Epid�emiologie. |0 (CaQQLa)201-0395682 | |
| 650 | 6 | |a Infections �a Staphylococcus aureus |0 (CaQQLa)201-0368280 |x Pathogen�ese. |0 (CaQQLa)201-0377536 | |
| 650 | 6 | |a Staphylococcus aureus |0 (CaQQLa)201-0092165 |x G�en�etique. |0 (CaQQLa)201-0380134 | |
| 650 | 6 | |a Bact�eries pathog�enes |x R�esistance aux m�edicaments. |0 (CaQQLa)201-0418450 | |
| 650 | 7 | |a SCIENCE |x Life Sciences |x Biology. |2 bisacsh | |
| 650 | 7 | |a SCIENCE |x Life Sciences |x Microbiology. |2 bisacsh | |
| 650 | 7 | |a Drug resistance in microorganisms |2 fast |0 (OCoLC)fst00898704 | |
| 650 | 7 | |a Staphylococcus aureus |2 fast |0 (OCoLC)fst01131544 | |
| 650 | 7 | |a Staphylococcus aureus infections |2 fast |0 (OCoLC)fst01131545 | |
| 700 | 1 | |a Ala'Aldeen, Dlawer A. A. | |
| 700 | 1 | |a Hiramatsu, Keiichi, |d 1949- | |
| 776 | 0 | 8 | |i Print version: |t Staphylococcus aureus |z 1898563969 |w (DLC) 2005391715 |w (OCoLC)55879419 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781898563969 |z Texto completo |